当前位置:首页 - 行情中心 - 万孚生物(300482) - 财务分析

万孚生物

(300482)

  

流通市值:94.30亿  总市值:102.56亿
流通股本:4.30亿   总股本:4.68亿

万孚生物(300482)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润1.90亿元,每股收益0.39元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益562740.35万元,未分配利润354250.27万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产690002.87万元,负债127262.52万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入1,245,654,367.05800,275,782.513,064,809,396.662,181,361,474.64
营业总成本1,069,201,644.31588,132,685.222,433,963,779.681,715,728,355.95
其他经营收益
营业利润207,841,628.6215,606,151.09636,845,288.18498,107,917.74
利润总额204,776,981.39215,017,806.11629,462,610.16492,835,920.6
净利润190,209,871.9190,072,222.04565,215,133.8439,816,270.6
每股收益
其他综合收益-37,344.56-27,967.44-27,150,639.65-222,870.57
综合收益总额190,172,527.34190,044,254.6538,064,494.15439,593,400.03
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计3,383,062,415.273,824,674,042.043,785,861,965.83,757,526,923.2
非流动资产:
非流动资产合计3,516,966,307.733,357,871,870.493,368,790,077.332,992,527,070.68
资产总计6,900,028,7237,182,545,912.537,154,652,043.136,750,053,993.88
流动负债:
流动负债合计591,777,965.85661,546,113.92821,464,141504,768,504.72
非流动负债:
非流动负债合计680,847,270.15680,776,518.41682,899,896.54678,650,808.68
负债合计1,272,625,2361,342,322,632.331,504,364,037.541,183,419,313.4
所有者权益(或股东权益):
归属于母公司股东权益合计5,551,415,349.415,743,386,505.555,554,388,042.845,470,222,938.09
股东权益合计5,627,403,4875,840,223,280.25,650,288,005.595,566,634,680.48
负债和股东权益合计6,900,028,7237,182,545,912.537,154,652,043.136,750,053,993.88
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计1,154,464,589.94557,099,837.332,601,230,864.981,949,008,494.63
经营活动现金流出小计1,210,776,041.2705,887,556.912,239,519,734.121,775,685,214.49
经营活动产生的现金流量净额-56,311,451.26-148,787,719.58361,711,130.86173,323,280.14
投资活动产生的现金流量:
投资活动现金流入小计2,572,611,7441,268,202,362.964,521,693,638.42,952,447,043.56
投资活动现金流出小计2,776,903,133.961,643,899,089.575,538,290,314.654,345,699,320.97
投资活动产生的现金流量净额-204,291,389.96-375,696,726.61-1,016,596,676.25-1,393,252,277.41
筹资活动产生的现金流量:
筹资活动现金流入小计3,134,503.782,386,986.95883,364,758.44868,154,476.56
筹资活动现金流出小计230,339,919.71160,000244,286,833.79223,376,534.22
筹资活动产生的现金流量净额-227,205,415.932,226,986.95639,077,924.65644,777,942.34
汇率变动对现金及现金等价物的影响635,699.82237,482.294,332,842.78-850,686.9
现金及现金等价物净增加额-487,172,557.33-522,019,976.95-11,474,777.96-576,001,741.83
期末现金及现金等价物余额340,930,471.32306,083,051.7828,103,028.65263,576,064.78
补充资料:
现金及现金等价物的净增加额-487,172,557.33--11,474,777.96-
最新报告期:2025-10-10
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
中信建投王在存,贺菊颖0.871.031.192025-10-10
华创证券郑辰,李婵娟0.891.051.262025-09-30
开源证券余汝意0.891.041.252025-08-21
信达证券唐爱金,曹佳琳0.841.041.282025-08-21
华泰证券代雯,高鹏,杨昌源0.881.021.212025-08-20
TOP↑